Bayer AG - brand history. Where is Bayer located? Reviews Bayer Pharm company official
1. Bayer invented heroin
For some (especially those who have studied the history of the drug trade) this is common knowledge, but many are shocked to learn that a company as old and big as Bayer is responsible for creating one of the most dangerous drugs in history. But frankly, it's not surprising that most people don't know about Bayer's connection to heroin, as the company has gone to great lengths to distance itself from its creation.
The drug that eventually became known as heroin was first created by C.R. Elder Wright in 1874, who simply experimented with morphine and did nothing with the substances he received. This drug was again independently synthesized only 23 years later by the chemist Felix Hoffmann, who was then working for the German company Aktiengesellschaft Farbenfabriken (the future Bayer company). Hoffamann was tasked with converting morphine into codeine to make a drug that was less potent and less addictive. But instead, he created a drug that was twice as strong as morphine.
Bayer did create and patent heroin (it was so named because it evoked a heroic feeling in those who took it) and marketed the drug as a cough suppressant and even specifically recommended it for children. The company even advertised heroin as a treatment for morphine addiction until it discovered that it quickly turns into morphine in the body.
The company lost many of its rights to the heroin-related trademark (along with aspirin) after the Treaty of Versailles in 1919, after which it was made by other third parties and then by drug dealers after it was banned in the US in 1924.
2. Bayer didn't formally invent aspirin.
Although Bayer has credited the creation of acetylsalicylic acid, or aspirin, to Felix Hoffmann (the chemist who synthesized heroin), and therefore to itself, the drug was actually first created in 1853 by chemist Charles Frédéric Gérard and subsequently self-replicated in many ways by many other chemists.
Most historians agree that Hoffmann did his research and was well aware of the previously used methods for obtaining aspirin and therefore, even by chance, could not invent this medicine, but simply found a way to make it safer and less bitter in taste. There is even evidence that Hoffmann was working on aspirin at the behest of his boss, and thus he didn't even create it himself. But, in any case, Bayer decided to list Hoffmann as the inventor in the 1899 US patent for this drug.
3 Bayer Tried To Keep Making Money In America During World War I
In 1899, Bayer patented aspirin, and this safe, effective drug that could be used for fever and pain quickly became its best-selling product. However, by the outbreak of the First World War in 1914, many companies around the world were already selling their versions of this drug. Shortly after the outbreak of the war, England banned the import of goods manufactured by German companies, including Bayer, and in 1915 Bayer was stripped of the rights to the aspirin trademark so that other companies could give this name to their drugs.
Unfortunately for Bayer, they not only lost markets, they also struggled to keep up with their production needs, since one of the main ingredients needed to synthesize aspirin was phenol, which was also used in the manufacture of explosives. Bayer still had a large market in the US and factories where it could produce aspirin for sale in North America, but it needed to find a supplier of phenol since it couldn't get it from Germany, so Bayer fell for the ruse, known as the Great Phenolic Conspiracy.
The big phenol conspiracy was complex, but mostly consisted of buying surplus phenol through a shell company from Thomas Edison, who set up his own factory to produce the substance, which was also needed to make phonographs. However, a few months later, a briefcase with details of this conspiracy was discovered by a Secret Service agent.
Although there was nothing illegal in this plot, since the United States had not yet entered the war at that time, the publication of information related to it in the media caused a big scandal. While the resulting phenol was sufficient to run its aspirin factories, the scandal ruined Bayer's reputation.
After the discovery of the Great Phenolic Plot, Bayer began opening more front companies and branches in the US to avoid losing control of its assets if the US entered the war. When the US declared war on Germany, an investigation was launched against Bayer, and then she moved her assets to a company that was formally American, but controlled by the same German-American leadership. However, this ruse was quickly discovered, and the government soon took control of Bayer's American assets and then sold all of its trademarks and patents, including the name and logo, to the medical company Sterling Products, Inc. Bayer AG eventually bought out all of its rights in 1994.
4 Bayer Made Some Of The Most Dangerous Gases Used During World War I
Here are two facts about the First World War that everyone knows: 1) soldiers were in the trenches, and 2) gases were among the most dangerous weapons of this war. But few people know that without Bayer, these chemical weapons might not have existed. It all started shortly before the war, when Bayer's chairman, Carl Duisberg, was one of three men tasked by the War Office to find uses for the toxic waste already produced by the chemical plants. This group recommended that they be used to produce chlorine, which Bayer then helped produce and ship to the front. Duisberg was even present at the first test of this chemical weapon.
Under the leadership of the same Duisberg, Bayer created more dangerous gases, including phosgene and mustard gas. It is estimated that over 60,000 people died from these gases during the First World War. And although not all of these people died from Bayer products, without this company, these deaths might not have happened at all.
5 Bayer War Crimes During World War II
After World War I, Bayer merged with a number of other chemical and medical companies in Germany to create a conglomerate called IG Farben, which was among the few companies that funded the Nazi Party and allowed Hitler to rise to power.
IG Farben owned a 40% stake in the company that made Cyclone B, which was used to exterminate people in the Auschwitz gas chambers, but that was far from the corporation's only role in the Holocaust. She was directly involved in some of the worst Nazi war crimes, as none other than Josef Mengele himself tested her drugs on healthy Jewish twins. The company also conducted its own experiments on Holocaust victims, buying them from the Nazis to infect them with various diseases and use them as lab rats. Most of the drugs that were tested during these experiments killed all the test subjects. IG Farben also made extensive use of concentration camp labor, for which Bayer apologized in 1995.
IG Farben was liquidated after World War II due to its war crimes, and Bayer was resurrected as an independent company. And, of course, she did everything possible to distance herself from these war crimes.
Source 6Bayer broke the law in making hemophilia drugs that gave people AIDS.
Some medicines, such as those used to treat hemophilia, are made from human blood. Not surprisingly, dangerous diseases could be transmitted quite easily with these drugs, which is why in the early 1980s, with the onset of the AIDS epidemic, the federal government banned the use of prisoners, intravenous drug users, and gay men as blood donors for these drugs. But Bayer ignored these laws and used blood pools from these populations in the production of its clotting factors VIII and IX for hemophiliacs. To make matters worse, since the company pooled the blood of all donors (more than 10,000 people), even a small number of sick donors could infect the entire pool.
As a result, a drug that was supposed to save lives has itself become potentially dangerous. According to tests conducted by the CDC in 1985, 74% of hemophiliacs who took this drug were infected with AIDS. Ultimately, about 20,000 hemophiliacs from around the world were infected with AIDS as a result of taking Bayer's coagulation factors VIII and IX. Since then, Bayer has paid over $600 million in compensation to hemophiliacs who contracted AIDS.
7 Bayer Continued To Sell Potentially Contaminated Drugs Outside The U.S. For Years
As if it wasn't enough that it had already infected thousands of people with AIDS, Bayer decided to continue selling its dangerous products in other countries, even after they had to be removed from drugstore shelves in the US and Europe. In fact, to neutralize the HIV virus in these drugs, they only needed to be subjected to heat treatment. But instead of selling only the safer version of these drugs and withdrawing the more dangerous version from the market, Bayer continued to sell the latter in Asian and Latin American countries. It even made new batches of old versions of drugs because they were cheaper to produce.
Bayer still maintains that she acted responsibly, ethically and humanely, offering many justifications for her behavior. Specifically, they state that buyers were hesitant about the effectiveness of the new drug, that some countries were slow to approve the sale of a safer drug, and that plasma shortages prevented them from producing more new drugs. However, despite all these claims, the company's internal filings show that even then, Bayer knew it was doing something wrong. In 1985, the company wondered if they could knowingly supply uncooked drugs to Japan, and yet they continued to do so.
8. At the end of the last century, Bayer was accused of fraud with Medicaid
Federal law requires drugs to be sold at the lowest price for Medicaid, and if a company offers a private insurance company or pharmacy to buy the drug at a lower price, it must refund the difference to Medicaid. By entering into an agreement with Kaiser Permanente in 1995, Bayer violated this law by agreeing to sell the antibiotic Cipro to the company at a lower price than for Medicaid, after Kaiser threatened to start using Johnson & Johnson's cheaper ofloxacin. Instead of complying with the law and notifying Medicaid of the price change, which would have required tens of millions of dollars in compensation, Bayer accepted Kaiser's offer to rename the drug and give it a different identification number. The year before, the company had done the same with its antihypertensive drug nifedipine.
In 2003, Bayer, despite continuing to claim that it acted responsibly, pleaded guilty and agreed to pay $257 million in damages and fines.
9. In many countries, Bayer still owns the patent for aspirin.
It may surprise you, but after all its war crimes and all the changes in ownership, Bayer still has a patent on aspirin in some countries. In fact, although the company lost the patent for the drug in the US, UK, and France during World War I, it retained its rights to it in Canada, Mexico, Germany, Switzerland, and more than 75 other countries.
Bayer has gone out of its way to support its patent and its brand, especially immediately after its introduction. When the company began manufacturing aspirin in 1899, it gave free samples of the drug to doctors, hospitals, and pharmacies and asked them all to report on its effectiveness. And when other companies started making their own aspirin, Bayer started making the drug in tablets (originally it was sold as a powder).
10 Bayer Was Accused Of Spreading The Spanish Flu To Boost Sales
Unlike the other items on this list, this item is just a conspiracy theory, but at the same time, Bayer would probably like to keep it a secret that since 1918, people have accused her of deliberately spreading the Spanish flu. While this conspiracy theory may not have any basis in fact, it's easy to see why people believed it. The fact is that this German company sold almost the only remedy for this disease.
It is also worth noting that one researcher, Karen Starko, argued that many of the deaths associated with the Spanish flu were actually caused by aspirin overdose, as the drug was still new and doctors did not know how much to prescribe and What does aspirin poisoning look like? But even Starko noted that this was just a guess, since she could not find reliable autopsy reports to find out if there were symptoms of aspirin poisoning.
Bayer AG is a German chemical and pharmaceutical company founded in Barmen (now part of Wuppertal, Germany) in 1836. Its headquarters is located in Leverkusen, North Rhine-Westphalia (Germany).
The history of the Bayer pharmaceutical concern began in 1836 in Barmen - now one of the districts of the city of Wuppertal. The founders of the company were Friedrich Bayer and Johann Friedrich Weskott.
Originally Friedr General Partnership. Bayer et comp., was engaged in the production of a new type of paint: synthetic dyes from coal tar derivatives.
At that time, the light industry in Germany was experiencing an increase in production and the need for inexpensive dyes was very high. The natural paints that were used in the past were very expensive and limited in quantity.
Thanks to the German legislation of that time and the industrial growth of the mid-19th century, the number of enterprises engaged in the production of synthetic dyes grew very quickly, but only large players with their own research base and using the opportunities of the world market were able to remain on the market. One of the company's innovations was the production of Anizarin, a red synthetic dye.
From 1836 to 1881, Bayer was able to significantly strengthen its position in the local market, from the Friedr. Bayer et comp." the company was transformed into a joint-stock company under the name "Farbenfabriken vorm. Friedr. Bayer & Co. ”, this is how the financial foundation of the future concern was laid. The number of employees increased from 3 to 300 people.
The company owes its scientific potential and numerous innovations to Karl Duisberg, founder of the scientific laboratory in Wuppertal-Elberfeld. Thanks to the work of this laboratory, new standards were set for industrial research, many innovative dyes were invented, and with the advent of the pharmaceutical department, many drugs unique to their time, including Bayer's most famous drug, aspirin.
"The drug of the century" - that's what they called "aspirin", was synthesized by Felix Hoffman. "Aspirin" was an excellent alternative to expensive and inaccessible salicin and salicylic acid, dangerous for the stomach - the main painkillers of that time. But for the commercial success of the new invention, the benefit alone was not enough.
The company applied a new marketing move for its time (now we would call it direct mail) - it spared no expense to publish a 200-page catalog of its products with a 30,000th print run, where the main emphasis was placed on the novelty - "aspirin". At that time, there were about 30,000 practicing physicians in Europe - and Bayer sent out its catalog to all of them free of charge.
As a result, thanks to clever marketing moves and the use of the world market, Bayer has sold approximately 1 trillion tablets since March 1899, when the Imperial Patent Office in Berlin registered the trademark. Thanks to the production of aspirin, Bayer has become one of the largest pharmaceutical companies in the world.
But in addition to the invention of aspirin, the company was able to create another sensation in the medical world. In 1898, under the leadership of Heinrich Dazer, a drug was created that relieved pain better than morphine and was safer at the same time, in addition, employees of the company's research laboratory, who tested the new drug on themselves, found a powerful emotional reaction. This new drug was "heroin". At that time, "heroin" was available in the form of pills and syrups and was prescribed for many diseases, from the flu to multiple sclerosis.
Thanks to numerous inventions and large revenues in the local market, the company began to expand into the world market, the creation of a worldwide sales network was a decisive factor in the continuous development of the company. From the very beginning, Bayer began to supply dyes and medicines to markets in many countries around the world.
By the early 20th century, over 80% of the company's revenue came from product exports. In 1865, the company acquired a share in the first foreign factory for the production of dyes from coal processing products. One of the first foreign enterprises was a factory in New York City.
In 1876, the first enterprise of the company outside Germany was opened in Moscow - the factory of aniline dyes "Friedrich Bayer and Co."
In 1904, the famous cross became the logo of the Bayer company. Since Bayer aspirin was only distributed by pharmacists and doctors and the company could not use its own packaging, the cross was printed on the tablets so that consumers could associate the company's name with aspirin.
The first serious test for Bayer was the First World War. Due to the conflict, the concern lost its sales markets and many subsidiaries. In the US, authorities confiscated the German company's facilities, along with patents and trademarks, and sold them to competitors.
In 1913, Bayer became one of the three largest German chemical companies, more than 10 thousand employees and workers around the world worked at the company's production facilities. The concern owned more than 8 thousand patents for various paints, medicines and chemicals. One of the achievements was winning a patent for synthetic rubber.
Due to its powerful scientific base, in the early years of the World War, Bayer's production was subordinated to military needs, instead of aspirin, the production of trinitrotoluene, the most powerful explosive, was started. In addition to trinitrotoluene, the production of poisonous substances was organized, including chlorine, phosgene and "mustard" gas.
Despite all the achievements, after the defeat of Germany in the First World War, not only the company's foreign assets were confiscated, but also all patents and trademarks, including Aspirin. In addition, the global economic crisis of the 1930s was a strong blow, the company was forced to reduce its staff by 20%.
In 1925, Bayer, together with former competitors BASF and Hoechst, merged into the chemical concern I.G. Farbenindustrie AG. As a result, despite the fact that the German economy was devastated by the war, the fourth largest global corporation arose in the country, which retained leadership in its industry. But the merger also had negative sides, until the 1950s, the Bayer trademark disappeared from the world market.
At this time, the company was engaged in new scientific developments, promising areas - synthetic rubber and polymers. Polyurethane was invented in the 1930s. But even greater success awaited the company in connection with the discovery of Gerhard Domagk, who discovered the therapeutic effect of sulfonamides. The researcher received the Nobel Prize in 1939, and the company received another unique scientific development.
During the Second World War, the potential of the company was in the hands of the Nazis, on the basis of the enterprises, the production of deadly gases and other poisonous substances was organized, among which was Cyclone-6, which was used in many concentration camps. In addition, dangerous drugs were tested on prisoners, slave labor was used in factories.
As a result, at the Nuremberg trials in 1947, the leaders of the united concern IG Farben were recognized as participants in war crimes. In 1950, IG Farben was split into 12 companies. As a result, Farbenfabriken Bayer AG reappeared in 1951. That is, the same companies entered the market of the chemical industry as before the unification of 1925.
Immediately after the war, the main problem was the restoration of foreign markets, despite the fact that the company for the second time in its history lost its foreign assets, including its valuable patents, Bayer's activities in the domestic market were extremely important.
The ruined country needed medicines, as well as other chemical products of the company, and the country's economy needed tens of thousands of jobs. In the early 1950s, Bayer began buying up foreign subsidiaries. Like 30 years ago, the main sales market was the United States and Latin America.
Despite all the post-war difficulties, Bayer did not stop its scientific development, as in the 19th century, innovative research brought the company big profits, in the 50s, various drugs for the treatment of cardiovascular diseases, dermatological antifungals and broad-spectrum antibiotics were created. The range of drugs was constantly growing and expanding, new production facilities were opened, and the number of personnel was growing. By 1963, the company employed more than 80,000 people.
The number of subsidiaries was growing, and for further development, a serious reorganization of the company was required. In 1971, the modern designation Bayer AG appeared, and the corporation reformed into a branch structure that replaced the functional organization introduced in the 1950s.
In 1957, Bayer entered a new market for oil products, this became possible after Bayer bought Deutsche BP, and formed a new enterprise, Erdolchemie GmbH. In addition, the company's success in photographic equipment and agriculture was significant.
In the 1970s, Bayer began active expansion into the American market. The company first acquired Cutter Laboratories Inc in 1974 and Miles Laboratories Inc in 1976, which allowed it to take a leading position in the US pharmaceutical market by 1978.
In the 1970s, Bayer was not only expanding production, but also actively began to care about protecting the environment. The first step was the launch of Europe's largest industrial water treatment plant in Dormagen. In addition, Bayer paid great attention to the propaganda of the struggle for the environment, and raised public awareness of this problem. In 1980, the Bayer Tower Biology organization began its work in Leverkusen, which was engaged in the organization of wastewater treatment from biological contamination.
In addition to propaganda, Bayer also reduced its own emissions. So from 1977 to 1987, the content of heavy metals in used water decreased by 85-99%, and the emission of harmful gases into the atmosphere - by 80%. As a result, the fight for the environment has grown into a global trend, and Bayer has spent about 5 billion German marks on environmental safety.
From the 1970s to the 1990s, Bayer experienced constant transformation in the face of ever more pronounced globalization and changing global market conditions.
In the late 1980s, due to political changes in Europe, the company began active production and marketing activities in eastern Germany. In the late 80s, a new factory was built in the city of Bitterfeld, which produced products for Eastern Europe.
Bayer did not weaken its influence on the American market, in 1990 the largest acquisition in the history of the company took place - the Canadian company Polysar Rubber Corporation, headquartered in Toronto, was acquired. With this deal, the Bayer Group became the world's largest supplier of raw materials to the rubber industry.
Since in the middle of the 20th century, Bayer lost the opportunity to sell its products in the US market under its own name, the restoration of the trademark was an extremely important task. This became possible only after the purchase of the company that owned the right to the Bayer trademark.
That company was Sterling Drug, which specializes in the manufacture of self-medicating drugs. With this purchase, Bayer was once again able to operate in the US under its own name using its famous logo.
By the end of the 20th century, Bayer had regained its role as the world's largest chemical pharmaceutical concern. Thanks to the success of the company, the city of Leverkusen has become a powerful industrial and scientific center in Germany, where scientific institutes and large enterprises have grown.
One of the main pillars of its success Bayer owes to the notorious “aspirin”, which has always been in demand and has always helped the company to stay afloat and make big profits. Thanks to his profitable invention, Bayer spent huge amounts of money on the development of non-core enterprises, which were often unprofitable.
In addition, profits from the production and sale of aspirin helped the company weather the economic turmoil. Not many companies succeeded in this, often global corporations abandoned unprofitable industries. And Bayer, even in the “black” year for the company in 2001, managed to avoid the crisis and the fall in production, in addition, the corporate structure of more than 120 thousand people around the world was preserved.
In 2001, Bayer was at the center of an international scandal. As a result of taking the drug Lipobay, which is responsible for lowering blood cholesterol, 52 people died in several countries around the world. As a result, Bayer has spent around 800 million euros on settling relationships with its customers.
In June 2006, Bayer AG sold its Bayer Diagnostics, a medical diagnostics business, to Siemens AG for €4.2 billion. With a turnover of 1.43 billion euros and 5,400 employees, the division was fully integrated into Siemens AG in the second quarter of 2007.
The year 2008 was met with great optimism by the company's management, and despite the difficult economic situation around the world, the company showed good results, in the first quarters the growth of assets amounted to more than 5% compared to the same period in 2007. Bayer HealthCare and Bayer CropScience showed themselves better than others - these two divisions, despite the crisis, are demonstrating active sales growth.
On November 2, 2010, Bayer AG signed an agreement to acquire Auckland-based veterinary company Bomac Group. Financial information has not been released due to non-disclosure obligations.
Bayer (BAYER) operates in accordance with the principles of sustainable development. The long-term commercial success of the company's products is ensured by the combination of the company's economic growth with environmental and social responsibility.
Bayer CropScience is the world's leading manufacturer and marketer of cutting-edge products and innovative inventions in crop protection and pest control.
The company's product range includes a wide range of varieties and hybrid forms of field crops.
Story
1873 - Friedrich Bayer (merchant) and Johann Westcott (master dyer) organize the Friedr. Bayer et comp, which produces synthetic dyes.
1881 - on the basis of the company, the joint-stock company Farbenfabriken vorm. Friedr. Bayer&Co" with about 300 employees.
1876 - organization of the first enterprise of azaline dyes in Moscow. Until that time, Bayer actively exported artificial dyes to Russia, satisfying up to 75% of demand.
1883 - a decision is made to expand production in Russia. Vladimir Stolyarov, a Moscow merchant, leases a factory in his name.
1884 - V. Stolyarov buys out the previously rented factory.
1885 - V. Stolyarov formalizes the ownership of the dyeing production. Theodore Betinger is the creditor. The company "Bergmann&vom Scheidt" was founded to carry out sales.
1897 - The company opens a sales agency and Friedr. Bayer & Co.
1898 - 908 - production facilities are expanding. New plots are acquired for the development of factories.
1912 - Weyer starts manufacturing pharmaceuticals. The company is transformed into a joint-stock company Chem. Fabrik Friedr. Bayer & Co. The company ranks second in imports of various products to Russia.
The First World War and revolution interrupt business relations between Bayer and Russian business.
1978 - Bayer office opens in Moscow.
1990s - Bayer CJSC is registered in Russia.
Branches
Today the company is represented in Russia by three divisions: Bayer CropScience, Bayer HealthCare, Bayer MaterialScience.
Bayer offices are open in Ukraine, Belarus, Kazakhstan, Uzbekistan.
The company has representative offices in 20 regions of the Russian Federation, covering not only the European, but also the Asian part of the country.
Industrial base
Bayer CropScience is headquartered in Monheim, Germany. The company has three divisions - Crop Protection, Biological Sciences, Environmental Protection. The close interaction of all departments ensures the success of the company with the consumer.
The company's manufacturing facilities are located.
> Bayer, CJSC (Moscow)
This information cannot be used for self-treatment!
Be sure to consult with a specialist!
CJSC Bayer is the Russian office of the international wide-profile concern Bayer. The sphere of interests of this company includes healthcare, agriculture and light industry (manufacture of products from polyurethane and polycarbonate).
ZAO Bayer's medical subgroup specializes in the development, testing and production of modern pharmaceuticals and medical devices. The task of the Russian division is to introduce Bayer medicines to the market. The company's production portfolio includes both prescription and non-prescription drugs. One of the narrow specializations of the company is the development and production of systems for monitoring the level of glycemia, which are in demand in endocrinology. The company's pharmaceutical production facilities are located in Germany, in Leverkusen.
Bayer also develops products for the treatment of animals, as well as products for the care of pets and farm animals. Some of the company's products are in demand in the automotive industry, agriculture, and at home.
CJSC Bayer produces the following medicines:
- drug from the group of chondroprotectors Teraflex used in osteoarthritis to strengthen and restore articular cartilage;
- line of products for the protection and treatment of the skin Bepanthen, which includes Bepanthen cream to prevent dry skin, Bepanthen ointment for the prevention of diaper dermatitis and diaper rash, Bepanthen Plus, which has a complex antiseptic effect;
- Bepantol emulsion- stretch mark remedy Bepanthol cooling foam for first aid for sun and other skin burns;
- medicine Skinoren for the treatment of acne;
- glucocorticoid drug Advantan in the form of a cream, emulsion, and ointment, the drug is effective for skin itching of various etiologies;
- hypoallergenic agent for the care of dry, sensitive skin - Dardia;
- balanced multivitamin complexes Supradin(recommended for adults) and Supradin Kids(for children from 3 years old);
- vitamins Elevit-pronatal– vitamin and mineral complex for pregnant women;
- vitamin complex berocca plus to restore and maintain overall performance;
- heartburn remedy- antacid drug Rennie;
- remedy for hemorrhoids Relief in the form of rectal suppositories;
- calcium preparation in combination with vitamin D3 - Calcemin Advance for the prevention of calcium deficiency and the treatment of osteoporosis;
- vasoconstrictor sprays Nazol, Nazol Advance, as well as sprays for children - Nazol Baby and Nazol Kids;
- preparations based on acetylsalicylic acid - Aspirin-S and Aspirin Complex;
- antipyretic Antiflu Kids for kids;
- analgesic drug Alka-Seltzer used mainly in hangovers to treat headaches and other symptoms;
- combined analgesic Saridon, effective for dental, menstrual and muscle pain;
- device for measuring glucose level - blood glucose meter CONTOUR™ TS and a device for taking blood for analysis - MICROLET™2;
- contrast agents Magnevist, Ultravist and Gadovist and systems for their introduction;
- Xarelto preparations and Aspirin Cardio for the prevention of thromboembolic complications;
- fluoroquinolone antibiotics Tsiprobay and Avelox;
- drug Levitra for the treatment of erectile dysfunction;
- hormonal remedy Nebido, an analogue of testosterone for the treatment of deficiency of this hormone in men;
- oral contraceptives Byzanne, Jess Plus, Yarina Plus, Angelica and Mirena, which also have a therapeutic effect in some diseases of the female genital area;
- anticancer drug Nexavar used to treat certain types of cancer;
- remedy for the treatment of occlusive diseases of the arteries - Ilomedin, the use of which can significantly alleviate the condition of patients;
- Iloprost- a drug for the treatment of pulmonary hypertension.
When buying drugs, pay attention to who is the manufacturer of the purchased drug. If you see a cross from the name of the company on the package, then you can be sure that the manufacturer is Bayer. This is a mark of time-tested quality. Ask your parents, for sure, and they will confirm that the medicines of this manufacturer are of the highest quality and effectiveness. Bayer is an international organization. The structure includes about 300 representative companies located in different countries of the world.
Story
From the very first days of its opening, the founders set themselves the goal of producing only high-quality products that are aimed at the benefit of people and improving their quality of life. This is not just a creed, but also a path to success. It is impossible to build a business for centuries if you save on quality.
Surprisingly, Bayer was founded in the 19th century. In 1863 it was organized in Germany, in the city of Barmen. But the name was given to the company not in harmony with the place. Just one of the leaders who were then at the helm was called Friedrich Bayer. By the way, at that time there was no talk about the production of medicines, although there were ideas and plans. The very first developments were related to the production of dyes.
Growth and development
Bayer gradually gained experience and increased production volumes. It soon split into three separate branches. The first is developing and the second is Consumer Health, which produces over-the-counter drugs. The third branch specializes in plant protection. This separation helped to maintain the highest bar in terms of quality.
Modern realities
Bayer is today not only a leading manufacturer of drugs, but also an employer with a worldwide reputation. In 2016, the number of employees of this giant concern was about 120 thousand people. This is a huge number. Sales volume is about 5 billion euros per year. Of course, the company's costs are also in the millions. But the management does not spare funds for new developments.
First drugs
And now let's go back a little and see what drug was developed in the first years of the company's work. The very first project of the pharmaceutical company Bayer was the invention of acetylsalicylic acid. And today this drug remains known and used. It is in every first aid kit, and they know it under the name "Aspirin".
The inventions of the concern were not always for the benefit of mankind. Around the same years, the release of another drug called "Heroin" began. No, at that time they did not yet know about its narcotic properties, it was used exclusively for peaceful purposes, for the treatment of coughs. Later, its other properties were discovered, which turned out to be a tragedy for mankind.
Quality assurance
Pharm. from the very first day, Bayer strictly monitored the observance of the declared quality. That is why the medicines produced are still valued on the world market. The concern is very jealous of its rights to new developments. Therefore, both created drugs were registered as trademarks and belonged to her unchanged until the First World War.
At the beginning of the 20th century, the company registered its own logo. This is a familiar and today's Bayer cross. But at that time, pills and drugs were issued by doctors or pharmacists and did not have their own packaging. Therefore, the concern took a very cunning move, which was still a novelty on the market at that time. For brand recognition, they began to print the logo directly on the tablets. In fact, a very convenient and practical marketing ploy.
Further developments
The history of Bayer is thousands of lives saved. Representatives of the concern have always been engaged in research activities. Even today, these developments are very important, they are used by pharmaceutical companies around the world. The period of the Second World War became a dark part of the history of the company. It was during this period that the chemists working in the concern produced a gas that was used in concentration camps. There is direct evidence in historical documents that the prisoners were used for scientific experiments, testing new drugs.
Modern history of the concern
After the end of World War II, the company's assets were sold to pay for war reparations. But Bayer's drugs were needed and important, so the English representatives decided to revive the company. It is from this time that one can begin counting its modern history.
Since the developments made it possible to produce a variety of groups of drugs, the enterprise was again divided into various branches, including:
- Bayer CropScience AG - manufacture of insecticides.
- Bayer HealthCare AG - pharmaceuticals.
- Bayer MaterialScience AG - high-tech polymers.
Return to the world stage
Only at the end of the 20th century was the company able to recover so much that it was possible to think about development. And the first step was the acquisition of an American company that produced over-the-counter drugs. Now the concern has again secured the trademark "Aspirin". From this moment begins its rapid growth and development. In America, mass production of drugs with their own logo is carried out.
Here, in the United States, the company's second research institute is opening very soon. Numerous studies and developments are underway. Practically next, a research center opens in Japan. This made it possible to quickly increase capacity and enter the world market. Today there is no country whose pharmacies do not sell drugs with a memorable cross.
Research work
Currently, despite the widest range of products, research work continues to be carried out, which are aimed at creating new substances. In parallel with this, biotechnological production is developing. The company's specialists work under the slogan: "Innovations for life". Today, priorities are given to developments in the field of oncology, cardiology, diagnostic imaging, and protection of women's health. Separately, the topic of the latest developments is improving the quality of life in multiple sclerosis.
The medical company Bayer, in addition to aspirin and heroin, also invented a drug called Prontosil. This is the first ever sulfonamide. But it has quite a few contraindications, so the company began to further study this area. The next invention was the antibiotic Ciprofloxacin. It has been widely used to treat anthrax as well as urinary tract infections. According to the reviews of domestic consumers, the drug is effective and efficient.
Modern drugs
Recent research is aimed at the invention of new substances that could more effectively help in the treatment of certain diseases. Biotechnological production is growing and developing, which allows us to meet the needs of the modern pharmaceutical industry. On what preparations can you see the famous cross today? It is quite difficult to list everything, so let's limit ourselves to only the most famous:
- Preparations for the treatment of colds and flu - "Teraflex", "Nazol".
- "Relief".
- "Calcemin".
- Contraceptive drugs - Yaz and Yasmin.
- Skin care products - "Bepanthen" and "Panthenol".
- Glucometers Contour and Elite.
The company's novelty is a drug that helps to reliably diagnose Alzheimer's disease in a patient. In this vein, the company's novelty is "Florbetaben".
The second drug, which is recommended to pay attention to, is Madecassol ointment. This is a wonderful drug that has a fantastic wound healing property. It is used to accelerate the healing of postoperative wounds. It helps a lot, according to numerous reviews, and for the healing of shallow cuts, burns and frostbite. What makes this effect possible? The active components of the drug activate the production of collagen, reduce swelling, due to which cicatricial formations on the skin are minimized.
Development strategies
The company pays special attention to the development of healthcare, increasing the availability of medicines. Company policy expresses a common understanding of the principles followed by all divisions. The company embodies its principles on four levels:
- openness and involvement. This is very important, because the company really takes into account the interests of all its employees, which increases the loyalty of each of them.
- Responsible business conduct. This applies to the policy of personnel management, product quality control.
- Integration into commercial activities.
- Solving social problems. That is the provision of jobs.
The Bayer company in Moscow is an actively developing enterprise that occupies a leading position in the pharmaceutical industry.
Cooperation proposals
According to management feedback, a huge holding is constantly in need of initiative minds who will help promote the company's business on the market. Bayer vacancies are published on the official website, as well as on major international resources. The company invites people to reach new heights by developing their careers. This is a chance to start working in a large innovative company, which, thanks to its employees, is one of the most important in the pharmaceutical industry.
Top management is well aware that success does not come by itself. It is created by people who are the main value of the company. Dedicated employees who want to work towards a long-term improvement in the quality of human life - this is a professional, competent, forward-looking team.
Instead of a conclusion
Bayer today has branches in almost every major city in the world. In Moscow, the address of the company's office is: 3rd Rybinskaya Street, Building 18, Building 2. The location of all other branches can be found on the official website. This company produces a number of drugs that we use regularly. Pay attention to the corporate logo, and you will understand that you have been familiar with the products of the concern for a long time. Judging by consumer reviews, the drugs are not cheap, but the result of the treatment is immediately visible. In addition, they have a minimum of side effects. This also applies to medicinal syrups that treat children.
Brief description of Reader from Adobe
JSC "Chemical-Pharmaceutical Plant "Akrikhin" Open Joint-Stock Company Chemical-Pharmaceutical Plant Akrikhin
Company History Akrikhin General Director